Non-tuberculous Mycobacterial Infections in Thoracic Transplant Candidates and Recipients

• Published in: Current infectious disease reports Vol. 20; no. 6; p. 14
• Main Authors: Rao, Mana, Silveira, Fernanda P.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2018; Springer Nature B.V
• Subjects: Epidemiology; Infectious Diseases; Lung transplants; Medicine; Medicine & Public Health; Morbidity; Mortality; N Theodoropoulos and S Pergam; Risk factors; Section Editors; Topical Collection on Transplant and Oncology; Transplant and Oncology (M Ison; Transplantation; Non-tuberculous mycobacteria; Thoracic transplantation; Transplantation; Mycobacterium abscessus
• ISSN: 1523-3847; 1534-3146
• DOI: 10.1007/s11908-018-0619-8

Purpose of Review To review and discuss the epidemiology, risk factors, clinical presentation, diagnosis, and treatment of non-tuberculous mycobacteria (NTM) in thoracic transplantation. Recent Findings Non-tuberculous mycobacteria are ubiquitous but are an uncommon cause of disease after solid organ transplantation. The incidence of infection is higher in thoracic transplant recipients than in abdominal transplant recipients, with most cases seen after lung transplantation. It is associated with increased morbidity and, occasionally, mortality. Infection in the pre-transplant setting can occur in lung transplant candidates, often posing a dilemma regarding transplant listing. Disease manifestations are diverse, and pulmonary disease is the most common. Diagnosis requires a high index of suspicion. Treatment requires a multiple-drug combination and is limited by drug-drug interactions and tolerability. Mycobacterium abscessus is a challenge in lung transplant recipients, due to its intrinsic resistance and propensity to relapse even after prolonged therapy. Mycobacterium chimaera is an emerging pathogen associated with contamination of heater-cooler units and is described to cause disease months after cardiothoracic surgery. Summary NTM infections in thoracic organ transplant recipients are uncommon but are associated with substantial morbidity and mortality. Data from larger multicenter studies is needed to better define the epidemiology of NTM in thoracic transplantation, best treatment options, and the management of infected transplant candidates.